BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23909592)

  • 1. Conventional IVF as a laboratory strategy to rescue fertility potential in severe poor responder patients: the impact of reproductive aging.
    Artini PG; Obino ME; Carletti E; Pinelli S; Ruggiero M; Di Emidio G; Cela V; Tatone C
    Gynecol Endocrinol; 2013 Nov; 29(11):997-1001. PubMed ID: 23909592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA; El Din RE
    Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro fertilization stimulation protocol for normal responder patients.
    Marci R; Caserta D; Lisi F; Graziano A; Soave I; Lo Monte G; Patella A; Moscarini M
    Gynecol Endocrinol; 2013 Feb; 29(2):109-12. PubMed ID: 22943624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of IVF outcomes using conventional insemination and ICSI in ovarian cycles in which only one or two oocytes are obtained.
    Fang C; Tang J; Huang R; Li LL; Zhang MF; Liang XY
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7):650-6. PubMed ID: 22819252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral antioxidants supplementation for women with unexplained infertility undergoing ICSI/IVF: randomized controlled trial.
    Youssef MA; Abdelmoty HI; Elashmwi HA; Abduljawad EM; Elghamary N; Magdy A; Mohesen MN; Abdella RM; Bar MA; Gouda HM; Ali AM; Raslan AN; Youssef D; Sherif NA; Ismail AI
    Hum Fertil (Camb); 2015 Mar; 18(1):38-42. PubMed ID: 24989721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study.
    Weiss A; Neril R; Geslevich J; Lavee M; Beck-Fruchter R; Golan J; Shalev E
    Fertil Steril; 2014 Aug; 102(2):419-23. PubMed ID: 24880653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
    Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
    Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
    Ye H; Huang G; Pei L; Zeng P; Luo X
    Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.
    Youssef MA; van Wely M; Mochtar M; Fouda UM; Eldaly A; El Abidin EZ; Elhalwagy A; Mageed Abdallah AA; Zaki SS; Abdel Ghafar MS; Mohesen MN; van der Veen F
    Fertil Steril; 2018 Feb; 109(2):289-301. PubMed ID: 29317127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fertilization is a successful treatment in endometriosis-associated infertility.
    Opøien HK; Fedorcsak P; Omland AK; Abyholm T; Bjercke S; Ertzeid G; Oldereid N; Mellembakken JR; Tanbo T
    Fertil Steril; 2012 Apr; 97(4):912-8. PubMed ID: 22341637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering final oocyte maturation with reduced doses of hCG in IVF/ICSI: a prospective, randomized and controlled study.
    Lin H; Wang W; Li Y; Chen X; Yang D; Zhang Q
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):143-7. PubMed ID: 21824709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel modified ultra-long agonist protocol improves the outcome of high body mass index women with polycystic ovary syndrome undergoing IVF/ICSI.
    Tu J; Lin G; Lu C; Gong F
    Gynecol Endocrinol; 2014 Mar; 30(3):209-12. PubMed ID: 24351071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
    Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.